Works matching IS 17762596 AND DT 2021 AND VI 16 AND IP 1

Results: 12

Results and Clinical Utilization of Foundation Medicine Molecular Tumor Profiling in Uterine and Ovarian Cancers.

Published in:

Targeted Oncology, 2021, v. 16, n. 1, p. 109, doi. 10.1007/s11523-020-00785-z

By:

Watson, Catherine H.;
Broadwater, Gloria;
Wong, Janice;
Spinosa, Daniel;
de Oca, Mary Katherine Montes;
Datto, Michael;
Green, Michelle;
Hubbard, Christopher;
McKinney, Matthew;
McCall, Shannon J.;
Havrilesky, Laura J.;
Strickler, John H.;
Berchuck, Andrew;
Strickland, Kyle C.;
Previs, Rebecca A.

Publication type:

Article

Updated Efficacy and Safety Outcomes for Patients with Well-Differentiated Pancreatic Neuroendocrine Tumors Treated with Sunitinib.

Published in:

Targeted Oncology, 2021, v. 16, n. 1, p. 27, doi. 10.1007/s11523-020-00784-0

By:

Fazio, Nicola;
Kulke, Matthew;
Rosbrook, Brad;
Fernandez, Kathrine;
Raymond, Eric

Publication type:

Article

Correction to: SB8: A Bevacizumab Biosimilar.

Published in:

2021

By:

Syed, Yahiya Y.

Publication type:

Correction Notice

Preclinical and Clinical Advances of Targeted Protein Degradation as a Novel Cancer Therapeutic Strategy: An Oncologist Perspective.

Published in:

Targeted Oncology, 2021, v. 16, n. 1, p. 1, doi. 10.1007/s11523-020-00782-2

By:

Yang, Xinrui;
Yin, He;
Kim, Richard D.;
Fleming, Jason B.;
Xie, Hao

Publication type:

Article

The Allele Frequency of EGFR Mutations Predicts Survival in Advanced EGFR T790M-Positive Non-small Cell Lung Cancer Patients Treated with Osimertinib.

Published in:

Targeted Oncology, 2021, v. 16, n. 1, p. 77, doi. 10.1007/s11523-020-00781-3

By:

Buder, Anna;
Hochmair, Maximilian J.;
Filipits, Martin

Publication type:

Article

Selective Oral MEK1/2 Inhibitor Pimasertib in Metastatic Melanoma: Antitumor Activity in a Phase I, Dose-Escalation Trial.

Published in:

Targeted Oncology, 2021, v. 16, n. 1, p. 47, doi. 10.1007/s11523-020-00767-1

By:

Lebbé, Céleste;
Italiano, Antoine;
Houédé, Nadine;
Awada, Ahmad;
Aftimos, Philippe;
Lesimple, Thierry;
Dinulescu, Monica;
Schellens, Jan H. M.;
Leijen, Suzanne;
Rottey, Sylvie;
Kruse, Vibeke;
Kefford, Richard;
Raymond, Eric;
Faivre, Sandrine;
Pages, Celine;
Gomez-Roca, Carlos;
Schueler, Armin;
Goodstal, Samantha;
Massimini, Giorgio;
Delord, Jean-Pierre

Publication type:

Article

Real-World Healthcare Resource Utilization in Patients with Classical Hodgkin Lymphoma Treated with Pembrolizumab and Nivolumab in the USA.

Published in:

Targeted Oncology, 2021, v. 16, n. 1, p. 85, doi. 10.1007/s11523-020-00778-y

By:

Laliberté, François;
Raut, Monika;
Yang, Xiaoqin;
Germain, Guillaume;
Nahar, Akash;
Desai, Kaushal D.;
MacKnight, Sean D.;
Sen, Shuvayu S.;
Duh, Mei Sheng

Publication type:

Article

Impact of Dose Reduction on Efficacy: Implications of Exposure-Response Analysis of Palbociclib.

Published in:

Targeted Oncology, 2021, v. 16, n. 1, p. 69, doi. 10.1007/s11523-020-00771-5

By:

Zheng, Jenny;
Yu, Yanke;
Durairaj, Chandrasekar;
Diéras, Véronique;
Finn, Richard S.;
Wang, Diane D.

Publication type:

Article

Selective Oral MEK1/2 Inhibitor Pimasertib: A Phase I Trial in Patients with Advanced Solid Tumors.

Published in:

2021

By:

Delord, Jean-Pierre;
Italiano, Antoine;
Awada, Ahmad;
Aftimos, Philippe;
Houédé, Nadine;
Lebbé, Céleste;
Pages, Celine;
Lesimple, Thierry;
Dinulescu, Monica;
Schellens, Jan H. M.;
Leijen, Suzanne;
Rottey, Sylvie;
Kruse, Vibeke;
Kefford, Richard;
Faivre, Sandrine;
Gomez-Roca, Carlos;
Scheuler, Armin;
Massimini, Giorgio;
Raymond, Eric

Publication type:

journal article

Phase I Study of Rucaparib in Combination with Bevacizumab in Ovarian Cancer Patients: Maximum Tolerated Dose and Pharmacokinetic Profile.

Published in:

Targeted Oncology, 2021, v. 16, n. 1, p. 59, doi. 10.1007/s11523-020-00780-4

By:

Lorusso, Domenica;
Maltese, Giuseppa;
Sabatucci, Ilaria;
Cresta, Sara;
Matteo, Cristina;
Ceruti, Tommaso;
D'Incalci, Maurizio;
Zucchetti, Massimo;
Raspagliesi, Francesco;
Sonetto, Cristina;
Sinno, Valentina;
Ronzulli, Dominique;
Giolitto, Serena;
de Braud, Filippo

Publication type:

Article

Prognostic Value of Soluble Programmed Cell Death Ligand-1 (sPD-L1) in Various Cancers: A Meta-analysis.

Published in:

Targeted Oncology, 2021, v. 16, n. 1, p. 13, doi. 10.1007/s11523-020-00763-5

By:

Li, Xiaoyang;
Zheng, Yu;
Yue, Fei

Publication type:

Article

Developing Symptom Lists for People with Cancer Treated with Targeted Therapies.

Published in:

2021

By:

Sodergren, Samantha C.;
Wheelwright, Sally J.;
Fitzsimmons, Deborah;
Efficace, Fabio;
Sprangers, Mirjam;
Fayers, Peter;
Harle, Amelie;
Schmidt, Heike;
Bottomley, Andrew;
Darlington, Anne-Sophie;
Benson, Charlotte;
Bredart, Anne;
Hentschel, Leopold;
Arraras, Juan Ignacio;
Ioannidis, Georgios;
Leahy, Michael;
Lugowska, Iwona;
Nicolatou-Galitis, Ourania;
Petranovic, Duska;
Rohde, Gudrun E

Publication type:

journal article